Aurigen Medical was created by 2015/2016 BioInnovate fellows Dr John Thompson and Tony O’Halloran as a structural heart and EP company, developing the first entirely trans-septal implant to treat both the stroke and arrhythmia risk associated with persistent atrial fibrillation. Following investment from the Enterprise Ireland Commercialisation Fund, the company announced in May 2018 that it received €2.5million in the latest round of Horizon 2020 SME Instrument funding, placing first out of total of 1,280 entrants. AuriGen Medical will use its new funding to speed up commercialisation of its novel medical device.

  • Established: 2017
  • Funding: €2.95 million
  • Status: Towards Commercialisation


Our Location

Situated on the prestigious campus of National University of Ireland Galway within the medieval city of Galway, European Capital of Culture in 2020, with equal easy access to the wilderness of Connemara in the west and the European mainland in the east, BioInnovate boasts a superb location.

Our affiliation with Stanford BioDesign has helped us to become one of the world’s leading innovation hubs with an immense debt of gratitude owed to Enterprise Ireland for both their financial and professional support in helping BioInnovate grow.

Contact Us Today
BioInnovate Ireland Block E
National University of Ireland Galway,
Ireland +353 (0)91 492 646